In June, the PTAB cancelled 366 (71.76%) instituted claims across 36 IPR and PGR Final Written Decisions, including decisions issued following remand from the Federal Circuit. After review, 107 (20.98%) instituted claims survived, and patent owners conceded 37 (7.25%) instituted claims through motions to amend or disclaimer. For comparison, the cumulative average cancellation rate of instituted claims in IPR, CBM, and PGR Final Written Decisions is about 72%.
On a per-case basis, no instituted or substitute claims survived in 21 (58.33%) decisions, all instituted claims survived in 7 (19.44%) decisions, and a mixed outcome occurred in 8 (22.22%) decisions. A mixed outcome occurs where at least one instituted or substitute claim remains patentable, and at least one is cancelled, in a Final Written Decision.
On a per-case basis, no instituted or substitute claims survived in 21 (58.33%) decisions, all instituted claims survived in 7 (19.44%) decisions, and a mixed outcome occurred in 8 (22.22%) decisions. A mixed outcome occurs where at least one instituted or substitute claim remains patentable, and at least one is cancelled, in a Final Written Decision.
The overall cumulative instituted claim survival rate in IPRs, CBMs, and PGRs through June 30, 2023, broken down by technology center, is as follows:
The cumulative number of Final Written Decisions through June 30, 2023, separated by technology center, is as follows:
Additional cumulative statistics on the Board's IPR, CBM, and PGR decisions, updated through June 30, 2023, are available here on the At the PTAB blog.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.